The Cancer Letter
Podcast Description
The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.
With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health.
This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.
Podcast Insights
Content Themes
Covers vital themes in oncology including cancer therapies, drug regulation, cancer research funding, and public health, with episodes discussing topics like cancer incidence rates, the impact of government policies on federal health employees, and significant scientific discoveries such as the EGFR mutation in lung cancer.

The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.
With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health.
This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.
Philadelphia has more NCI cancer centers than the average American city.
The metropolis is home to four heavy-hitters: Fox Chase Cancer Center, the Abramson Cancer Center at the University of Pennsylvania, the Sidney Kimmel Cancer Center at Thomas Jefferson University, and the Wistar Institute.
In recent years, the four institutions have decided that working collaboratively suits them better than working competitively.
“We don’t work competing against one another. We have all this riches within our three to four institutions,” Robert A. Winn, director of Fox Chase Cancer Center, said in the November episode of The Directors. “I think we have the potential of delivering a much bigger impact between our cancer centers working together than working individually.”
The four cancer centers have formed a partnership in which they share catchment areas, expand community outreach and engagement, and advance translational research through clinical trials.
“The Northern Star is about patients. It’s about ending cancer as we know it here in this town—and this region, which stretches down into Delaware, out west to Pennsylvania, and into central New Jersey,” Robert Vonderheide, director of the Abramson Cancer Center at the University of Pennsylvania, said on the podcast.
The directors acknowledged that collaboration is not the norm.
“We’ve made jokes—‘Well, we actually can sit in the same room. We do like each other. We do talk to each other’—and people laugh,” Andrew Chapman, director of the Sidney Kimmel Cancer Center at Thomas Jefferson University, said. “Somebody at ECOG from New York raised their hand and said, ‘This will never happen in New York.’ I was just like, ‘Okay, well, that’s a problem.’”
On the November episode of The Directors, a monthly series on The Cancer Letter Podcast which focuses on the problems that keep directors of cancer centers up at night, three Philadelphia cancer center directors discuss what they’re calling “a bench to bedside to block model,” which they hope other cities nationwide may one day replicate.
Guests on this episode:
Robert A. Winn, director of Fox Chase Cancer Center
Robert Vonderheide, director of the Abramson Cancer Center at the University of Pennsylvania
Andrew Chapman, director of the Sidney Kimmel Cancer Center at Thomas Jefferson University
The podcast is moderated by Paul Goldberg, editor and publisher of The Cancer Letter and sponsored by the American Society of Clinical Oncology.
Read more and access the full transcript: https://cancerletter.com/podcastc/20261120_1/

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.